Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Pain, Tenderness, Vaccination site erythema
Clinical narrative: moderate aches and joint pains 8-36 hours following vaccine; moderate aches and joint pains 8-36 hours following vaccine; tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter) - the area is sore and red and warm to the touch; tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter) - the area is sore and red and warm to the touch; tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter) - the area is sore and red and warm to the touch; tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter) - the area is sore and red and warm to the touch; tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter) - the area is sore and red and warm to the touch; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 22Oct2021 12:15 (Lot number: FF2589, Expiration Date: 31Mar2022) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "high blood pressure:Hypertension" (unspecified if ongoing), notes: Other medical history:high blood pressure; "sulfa allergy" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE; INCASSIA. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247, Vaccine Administration Time: 01:00 PM, Route of Administration: Intramuscular), administration date: 15Mar2021, when the patient was 50 years old, for Covid-19 immunization; Bnt162b2 (Prev dose lot number=EL3247, Prev dose lot unknown=False, Prev dose administrator route=Intramuscular, Prev dose administration date=22Feb2021, Prev dose administration time=03:30PM, Prev dose dose number=1, Batch/Lot number: EL3247 exp:21May2021), administration date: 22Feb2021, when the patient was 50 years old, for Covid-19 immunization; Flu, administration date: 15Sep2021. The following information was reported: PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 24Oct2021 21:00, outcome "recovering" and all described as "moderate aches and joint pains 8-36 hours following vaccine"; TENDERNESS (non-serious), ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious), VACCINATION SITE WARMTH (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 24Oct2021 21:00, outcome "recovered" and all described as "tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter) - the area is sore and red and warm to the touch". Therapeutic measures were not taken as a result of pain, arthralgia, tenderness, erythema, vaccination site pain, vaccination site warmth, vaccination site erythema. No follow-up attempts are possible. No further information is expected.  Reporter consider the Pfizer product had a casual effect to the adverse event.  Additional information: The patient did not have covid prior vaccination, not tested for covid post vaccination. Patient did not receive any recent vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 vaccine prior to the event being reported. Concomitant medication included multivitamin. Clinical course: It was reported that moderate aches and joint pains 8 to 36 hours following vaccine; 48 hours later a tender red patch appeared on right arm just below the injection site area (about 3 inches in diameter), the area is sore and red and warm to the touch.